Market Research Logo

Glucose Monitoring Global Market - Forecast to 2025

Glucose Monitoring Global Market - Forecast to 2025

Glucose Monitoring consists of products that are essential for patients suffering from diabetes. With the projected rise in the aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the Glucose Monitoring global market is expected to grow at single digit CAGR to reach $12,897.0 million by 2025. Factors driving the Glucose Monitoring market are a global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products, and an increase in R&D investments are driving the market growth. Increase in obesity population due to lifestyle changes, increase in urbanization, untapped markets like the Middle East, Africa shows that glucose monitoring market has vast opportunities in the coming years. Frequent product recalls i.e. glucose testing strips due to manufacturing defects or supply of expired test strips and less product differentiation among the self blood glucose monitors are the factors that are restraining the market growth. The limited reimbursement facilities and alternative treatments that include cell-based assays, biomarkers identification and artificial pancreas and high cost associated with Continuous Glucose Monitoring (CGM) are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The products segment is divided into three segments i.e., Invasive, Non-Invasive and lab-based glucose monitoring products. The Invasive glucose monitoring products segment accounted the largest share in 2018 and is projected to grow at a low single digit CAGR from 2018 to 2025 due to technological advancements, easy use, patient-friendly, etc. Invasive products are classified into Self glucose monitoring and continuous glucose products. The self glucose monitoring segment accounted for the largest share in 2018 due to the development of minimally invasive products. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2018 due development of no coding strips. The continuous glucose monitoring market includes sensors/receiver and transmitter. The continuous glucose market includes products sensors/receiver and transmitter. Continuous glucose segment is the fastest growing segment and is projected to grow at a strong double digit CAGR from 2018 to 2025.

Based on sample type the market is segmented into blood, urine and others. The blood segment accounted for the largest share in 2018 due to the accuracy of results. Other source based glucose monitoring segment is fastest growing segment and is projected to grow exponentially from 2018 to 2025 due to increases R&D investment, many products is CE approved and expected launch very soon in the market.

Based on end users the market is segmented into hospitals, private clinics, home care and ambulatory settings. Among end-users, home care segment accounted for the largest share in 2018 and is projected to grow at a low single digit CAGR from 2018 to 2025 due to the availability of over the counter (OTC) self blood glucose monitor and ease in operating these monitors and thereby reducing the frequent visits to hospitals or clinics for checking glucose levels.

Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share followed by Europe. The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of glucose monitoring market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for glucose monitoring products.

Major players in Glucose monitoring market include Abbott Laboratories (U.S.), Roche (Switzerland), LifeScan (U.S.), Dexcom (U.S.), Medtronic, Inc. (Ireland), Ascensia (Switzerland), Arkray (Japan), Sinocare (China), B. Braun Melsungen AG (Germany), Bio-Rad (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • Italy
  • France
  • Others
  • Asia-Pacific
  • Japan
  • China
  • India
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle-East (Middle East & Others)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 The global rise in the prevalence and incidence of diabetes
3.3.1.2 Technological advancements in glucose monitoring devices
3.3.1.3 Increasing demand for less invasive devices or point of care
3.3.1.4 Increasing R & D investments
3.3.2 RESTRAINS AND THREATS
3.3.2.1 Availability of alternative treatment
3.3.2.2 High cost associated with the products
3.3.2.3 Inadequate reimbursement
3.3.2.4 Product recalls
3.3.2.5 Strict regulation of glucose monitoring devices by regulatory organizations like the FDA and others.
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.6 PATENT ANALYSIS
3.7 TECHNOLOGY ADVANCEMENTS
3.7.1 ARTIFICIAL INTELLIGENCE AND RADAR TECHNOLOGY
3.7.2 NON-INVASIVE CONTINUOUS GLUCOSE MONITORING WEARABLE
3.7.3 TEAR GLUCOSE MONITORING TECHNOLOGY
3.7.4 SALIVA BASED BIOSENSORS
3.7.5 MICRONEEDLE PATCH
3.7.6 PHOTOTHERMAL DETECTION OF GLUCOSE LEVELS
3.8 PRODUCT LAUNCHES AND APPROVALS
3.9 FUNDING SCENARIO
3.10 GLUCOSE MONITORING - DEALS
3.11 CLINICAL TRIAL DATA
3.12 PORTER’S FIVE FORCE ANALYSIS
3.12.1 THREAT OF NEW ENTRANTS
3.12.2 THREAT OF SUBSTITUTES
3.12.3 BARGAINING POWER OF SUPPLIERS
3.12.4 BARGAINING POWER OF BUYERS
3.12.5 RIVALRY AMONG EXISTING COMPETITORS
3.13 SUPPLY CHAIN ANALYSIS
3.14 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.14.1 GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
3.14.2 SELF BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE
ANALYSIS
3.14.3 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET
SHARE ANALYSIS
4 GLUCOSE MONITORING GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INVASIVE GLUCOSE MONITORING
4.2.1 SELF GLUCOSE MONITORING
4.2.1.1 Blood glucose meter
4.2.1.2 Blood glucose testing strips
4.2.1.3 Lancets
4.2.1.4 Others
4.2.2 CONTINUOUS GLUCOSE MONITORING
4.2.2.1 Glucose Sensors
4.2.2.2 Transmitters and Receivers
4.3 NON-INVASIVE GLUCOSE MONITORING
4.4 LAB BASED GLUCOSE MONITORING
5 GLUCOSE MONITORING GLOBAL MARKET, BY SAMPLE SOURCE
5.1 INTRODUCTION
5.2 BLOOD-BASED GLUCOSE MONITORING
5.3 URINE BASED GLUCOSE MONITORING
5.4 OTHER SOURCES BASED GLUCOSE MONITORING
6 GLUCOSE MONITORING GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME CARE
6.4 PRIVATE CLINICS
6.5 AMBULATORY SETTINGS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 ITALY
7.3.3 FRANCE
7.3.4 REST OF EUROPE
7.4 ASIA - PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF ASIA-PACIFIC
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 MIDDLE EAST & OTHERS
7.5.3 REST OF LATIN AMERICA
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 COLLABORATION & PARTNERSHIPS
8.4 OTHER DEVELOPMENTS
9 MAJOR COMPANIES
9.1 ABBOTT LABORATORIES, INC
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ARKRAY, INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ASCENSIA DIABETES CARE HOLDINGS AG.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 B.BRAUN MELSUNGEN AG
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 BIO-RAD LABORATORIES
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 DEXCOM, INC.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 LIFESCAN (JOHNSON & JOHNSON)
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MEDTRONIC, PLC
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 SINOCARE INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 ROCHE HOLDINGS AG
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report